Glenmark gets USFDA nod for generic antipsychotic drug

The company has received approval from the United States Food and Drug Administration (USFDA) for Chlorpromazine Hydrochloride tablets USP, in the strengths of 10 mg, 25 mg, 50 mg, 100 mg, and 200 mg, Glenmark said in a regulatory filing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/399YnKp
via IFTTT